Results for tris pharma

Add to feed Create your own feed

Latest

RECALL ALERT: Tris Pharma Inc. has expanded its voluntary recall of its infants’ liquid ibuprofen after discovering higher concentrations of the medication in some packages.

RECALL ALERT: Tris Pharma Inc. has expanded its voluntary recall of its infants’ liquid ibuprofen after discovering higher concentrations of the medication in some packages.

Tris Pharma, responsible for the recent recall of infant ibuprofen, has previously been called out by the FDA for its manufacturing process

New Jersey drugmaker Tris Pharma's recent recall of ibuprofen comes less than a year after federal regulators cited numerous manufacturing violations against the company

tweet picture

RECALL UPDATE FROM : Tris Pharma, Inc. is expanding its November 2018 recall of Ibuprofen Oral Suspension Drops. Some units have been found to have higher levels of Ibuprofen concentration. Find more information at:

tweet picture

Tris Pharma Inc. has voluntarily recalled three lots of infants’ liquid ibuprofen sold at Walmart, CVS, and Family Dollar, because they may contain too much ibuprofen. What to know about the newly recalled products:

tweet picture

Tris Pharma Inc. on Thursday expanded the voluntary recall of infant ibuprofen that it began in early December.

RT Tris Pharma Inc. has voluntarily recalled three lots of infants’ liquid ibuprofen sold at Walmart, CVS, and Family Dollar, because they may contain too much ibuprofen. What to know about the newly recalled products: … #health  #w 

tweet picture

? RECALL ALERT ?: In late 2018, Tris Pharma, Inc. voluntarily recalled three lots of Infants' Ibuprofen. Now, in the midst of cold and flu season, they’ve extended their original recall to include three more batches❗️

RECALL ALERT: Check your baby's medicine because Tris Pharma has expanded its voluntary recall of infants' ibuprofen oral suspension drops. Find the link for FDA recalls on .

Loading
Loading

Most relevant

There is a "remote possibility" that a side effect of the increased amount of ibuprofen could be permanent kidney injury in certain infants, Tris Pharma's release says.

Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Infants’ Ibuprofen Concentrated Oral Suspension (50 mg per 1.25 mL) by: Tris Pharma: Recall - Due to Potential Higher Concentrations of Ibuprofen

➡️ U.S. and China trade talks will resume today when POTUS meets with China's Vice Premier Liu He at the White House ➡️ Drug maker Tris Pharma is expanding its recall of infant ibuprofen ➡️ NASA researchers found a gigantic hole growing in Antarctica's Thwaites glacier

RECALL ALERT ⚠️ announces that Tris Pharma, Inc. has voluntarily recalled 3 lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, due to potential higher concentrations of ibuprofen.

tweet picture

#RecallAlert : Three lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) have been recalled by Tris Pharma, Inc., due to potentially higher concentrations of ibuprofen found in the product:

RECALL ALERT ⚠️ This week, announced that Tris Pharma, Inc. has voluntarily recalled 3 lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, due to potential higher concentrations of ibuprofen.

tweet picture

Loading
Loading